These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8750363)

  • 21. Pretransplant test-dose pharmacokinetic profiles: cyclosporine microemulsion versus corn oil-based soft gel capsule formulation.
    Chueh SC; Kahan BD
    J Am Soc Nephrol; 1998 Feb; 9(2):297-304. PubMed ID: 9527407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical development of a cyclosporine microemulsion in transplantation.
    Kovarik JM; Mueller EA; Niese D
    Ther Drug Monit; 1996 Aug; 18(4):429-34. PubMed ID: 8857563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New cyclosporine microemulsion randomized, cross-over bioequivalence steady-state study in renal transplanted patients.
    Sinescu I; Lopes HV; Foschi D; Jen LH; Oliani C
    Eur Rev Med Pharmacol Sci; 1999; 3(1):11-8. PubMed ID: 10710824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of cyclosporine malabsorption in diabetic recipients of simultaneous pancreas and kidney transplant using a microemulsion formulation.
    Chapman JR; O'Connell PJ; Bovington KJ; Allen RD
    Transplantation; 1996 Jun; 61(12):1699-704. PubMed ID: 8685946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in bioavailability between oral cyclosporine formulations in maintenance renal transplant patients.
    Curtis JJ; Barbeito R; Pirsch J; Lewis RM; Van Buren DH; Choudhury S
    Am J Kidney Dis; 1999 Nov; 34(5):869-74. PubMed ID: 10561143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation.
    Roza A; Tomlanovich S; Merion R; Pollak R; Wright F; Rajagopalan P; Pruett T; Scandling J; Ryan J; Awni W; Schweitzer S; Greco R; Lam W; Nabulsi A; Hoffman R
    Transplantation; 2002 Oct; 74(7):1013-7. PubMed ID: 12394847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cyclosporine level in blood as monitored by area-under-the-curve (AUC). III. The influence of absorption phase after orally dosing].
    Yuhki Y; Tadano K; Takahashi Y; Iseki K; Miyazaki K; Hirano T
    Yakugaku Zasshi; 1994 Aug; 114(8):589-96. PubMed ID: 7932103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of an oral solution of the microemulsion formulation of cyclosporine in maintenance pediatric liver transplant recipients.
    Dunn S; Cooney G; Sommerauer J; Lindsay C; McDiarmid S; Wong RL; Chang CT; Smith HT; Choc MG
    Transplantation; 1997 Jun; 63(12):1762-7. PubMed ID: 9210501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of cyclosporin A pharmacokinetics of a new microemulsion formulation and standard oral preparation in patients with psoriasis.
    Erkko P; Granlund H; Nuutinen M; Reitamo S
    Br J Dermatol; 1997 Jan; 136(1):82-8. PubMed ID: 9039300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic conversion study of a new cyclosporine formulation in stable adult renal transplant recipients.
    Perlík F; Masri MA; Rost M; Kamarád V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):309-13. PubMed ID: 16601778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced intrapatient variability of cyclosporine pharmacokinetics in renal transplant recipients switched from oral Sandimmune to Neoral.
    Mendez R; Abboud H; Burdick J; Copley B; Freeman R; Batiuk TD; Cooney GF; Barbeito R
    Clin Ther; 1999 Jan; 21(1):160-71. PubMed ID: 10090433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Time-dependent changes in cyclosporine exposure: implications for achieving target concentrations.
    Felipe CR; Silva HT; Machado PG; Garcia R; Moreira SR; Pestana JO
    Transpl Int; 2003 Jul; 16(7):494-503. PubMed ID: 12677364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of cyclosporin in children with stable renal transplants.
    Tam JC; Earl JW; Willis NS; Farquhar JE; Nath CE; Knight JF; Hodson EM
    Pediatr Nephrol; 2000 Dec; 15(3-4):167-70. PubMed ID: 11149104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
    Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C;
    Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of conventional oral cyclosporine and cyclosporine microemulsion formulations in children with a liver transplant.
    Hoppu K; Jalanko H; Laine J; Holmberg C
    Transplantation; 1996 Jul; 62(1):66-71. PubMed ID: 8693548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cyclosporine disposition and metabolite profiles in renal transplant patients receiving a microemulsion formulation.
    Kovarik JM; Vernillet L; Mueller EA; Freiburghaus R; Niederberger W; Kutz K
    Ther Drug Monit; 1994 Oct; 16(5):519-25. PubMed ID: 7846753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disposition of two oral formulations of cyclosporine in pediatric patients receiving hematopoietic stem cell transplants.
    Dupuis LL; Taylor T; Saunders EF
    Pharmacotherapy; 2006 Jan; 26(1):15-22. PubMed ID: 16509024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conversion and pharmacokinetic studies of a microemulsion formulation of cyclosporine in pediatric liver transplant patients.
    D'Agostino D; Gimenez M; Yamaguchi B; Glancszpigel R; Vinuesa F; Gamba M; Ciardullo M; de Santibaes E
    Transplantation; 1996 Oct; 62(8):1068-71. PubMed ID: 8900303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial pharmacokinetic interaction between cyclosporine and itraconazole in renal transplant recipients.
    Florea NR; Capitano B; Nightingale CH; Hull D; Leitz GJ; Nicolau DP
    Transplant Proc; 2003 Dec; 35(8):2873-7. PubMed ID: 14697925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.